Red Yeast Rice Labels: A Rice Quantity Does Not Establish a Monacolin Amount
Separate the declared fermented-rice quantity, a citrinin statement and the specific US restriction concerning enhanced or added lovastatin.
We have not performed hands-on testing of the products discussed. Manufacturer references and official guidance support the documented information below; comparison exercises are our editorial guidance.
An ingredient name may contain the word rice while raising a constituent question that the printed quantity does not answer. A buyer cannot resolve that question by assuming all fermented material has a fixed composition. This guide examines one current manufacturer panel and the limited US regulatory distinction described by NCCIH, without making a clinical comparison or recommending a product.
Record what the actual panel quantifies
NOW’s consulted Red Yeast Rice 600 mg page identifies Monascus purpureus and gives an organic red yeast rice quantity in its Supplement Facts panel. It does not provide a separate monacolin K quantity in that panel. The documented amount is therefore a quantity of the named fermented material. It should not be copied into a monacolin field, a lovastatin field or a medicine-equivalence calculator. The front number does not fill an undeclared constituent field.
Keep the fermentation by-product statement separate
The manufacturer also describes production intended to avoid citrinin. That statement concerns a different named substance from monacolin K. Preserve the company’s wording and scope rather than treating it as a measured monacolin result. This guide has not examined a lot-specific laboratory report and does not certify the delivered contents. A statement about one fermentation-related substance cannot answer every composition question about a complex material.
Read the precise US category limitation
NCCIH explains that monacolin K is structurally identical to lovastatin and describes FDA’s position that red yeast rice with enhanced or added lovastatin cannot be marketed as a dietary supplement in the United States. Keep the enhanced-or-added qualification. It is not a blanket finding about every product bearing the ingredient name, and it does not establish the status of this particular bottle. This US explanation also does not decide the rules for an EU offer.
Worked example: correct an unsupported equivalence row
Imagine an illustrative seller comparison copies the rice quantity into a column headed active monacolin and uses a citrinin statement as confirmation. Delete both inferences. Keep the declared material amount, the absent constituent declaration and the attributed citrinin statement in separate fields. Request the basis for any exact constituent claim the seller makes. Do not estimate a constituent percentage from another product, a research average or the word fermented. The corrected record may still contain an unresolved question, which is more useful than false precision. If the purchase depends on a medical effect or a comparison with a prescribed medicine, provide the actual label to an appropriate professional. This guide supplies no substitution, treatment, intake, safety or effectiveness conclusion. It identifies why a rice-mass number and an unrelated production statement are insufficient to complete the buyer’s original constituent question.
Compare the trade-offs
| Option | Useful when | Purchase limitation |
|---|---|---|
| Fermented-rice quantity | Declared amount of the named material | Not a monacolin or lovastatin amount |
| Citrinin production statement | Attribute the specific manufacturer wording | Does not establish another constituent’s quantity |
| US enhanced/added restriction | Retain the precise qualification and jurisdiction | Not a legal finding about every named product |
Your purchase checklist
- Leave an undeclared monacolin quantity unresolved.
- Keep citrinin and monacolin statements in different fields.
- Do not derive medicine equivalence from fermented-rice mass.
Sources and further reading
- NOW: Red Yeast Rice 600 mg current ingredient panel and production statement
- NCCIH: red yeast rice constituents and the specific US regulatory limitation
Reference links concern the stated topic or example. They do not indicate endorsement of this publication. Product versions, local labels, availability and seller terms can change; verify the exact listing before ordering.